Literature DB >> 33136735

Identifying Regions of Greatest Need for Ending the HIV Epidemic: A Plan for America.

Mia Moore1, Marie-Claude Boily2, Kate M Mitchell2, Deborah D Donnell1, Myron S Cohen3,4,5, Dobromir T Dimitrov1,6.   

Abstract

BACKGROUND: In the 2019 State of the Union Address, President Trump announced a plan for "Ending the HIV Epidemic" in the United States, with a goal to reduce new HIV infections by 90% by 2030. Phase I of the plan set an intermediate goal of a 75% reduction within 5 years, focusing on select states and counties.
METHODS: We assessed the feasibility of the first phase of the plan by estimating the fraction of HIV diagnoses that occur within the targeted region, using a statistical model to predict new HIV cases in each county. We suggested new areas that should be added to the current plan, prioritizing by both a "Density Metric" of new HIV cases and a "Gap Metric" quantifying shortcomings in antiretroviral therapy and pre-exposure prophylaxis uptake.
RESULTS: We found the current plan targets less than 60% of new diagnoses. The plan should be expanded to Puerto Rico, Florida, Georgia, Louisiana, and Maryland as well as parts of New York, North Carolina, Texas, and Virginia, areas which were prioritized by both metrics.
CONCLUSION: Many of the highest priority areas, both by density of HIV cases and by lack of viral suppression and pre-exposure prophylaxis use, were not covered by the original plan, particularly in the South. The current plan to end the HIV epidemic must be expanded to these areas to feasibly allow for a 75% reduction in new HIV cases within 5 years.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33136735     DOI: 10.1097/QAI.0000000000002477

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  2 in total

1.  How Can Progress Toward Ending the Human Immunodeficiency Virus Epidemic in the United States Be Monitored?

Authors:  Kate M Mitchell; Mathieu Maheu-Giroux; Dobromir Dimitrov; Mia Moore; James P Hughes; Deborah Donnell; Chris Beyrer; Wafaa M El-Sadr; Myron S Cohen; Marie Claude Boily
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

2.  HIV Infection Prevalence Significantly Intersects With COVID-19 Infection At the Area Level: A US County-Level Analysis.

Authors:  Hui Luan; Insang Song; David A Fiellin; Yusuf Ransome
Journal:  J Acquir Immune Defic Syndr       Date:  2021-10-01       Impact factor: 3.771

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.